Bristol Myers tops revenue expectations on strength of older drugs, shares fall – Reuters

  1. Bristol Myers tops revenue expectations on strength of older drugs, shares fall  Reuters
  2. Bristol Myers touts commercial execution, reckons with recent clinical setbacks  Fierce Pharma
  3. Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top Estimates  Yahoo Finance
  4. Bristol Myers Squibb Reports Second Quarter Financial Results for 2025  BioSpace
  5. Bristol Myers raises revenue guidance for the year, prepares for major Cobenfy readouts  Endpoints News

Continue Reading